Haifeng Shi | Infectious Diseases | Excellence in Research 

Dr. Haifeng Shi | Infectious Diseases | Excellence in Research 

Jiangsu University | China

Author Profile

Scopus

Dr. Shi Haifeng: Pioneer in Metal Toxicology and Cell Damage Detection 🔬

EARLY ACADEMIC PURSUITS 🎓

Dr. Shi Haifeng's academic journey began with a Bachelor’s degree in Biochemistry from Nanjing University in 1998. His passion for biochemistry led him to pursue a Ph.D. at the Hong Kong University of Science and Technology, where he studied under the mentorship of Professor Hong Xue, earning his doctorate in 2002. This foundation set the stage for his future groundbreaking research in the field of metal ion metabolism and toxicity.

PROFESSIONAL ENDEAVORS 🧑‍🔬

After obtaining his Ph.D., Dr. Shi continued his work at the Hong Kong University of Science and Technology as a Research Associate from 2002 to 2004, further honing his research skills. He then embarked on an international academic experience as a Visiting Scholar at the National Institutes of Health (NIH), specifically within the Liver Diseases Branch of the NIDDK, from 2004 to 2009. His time at the NIH allowed him to deepen his expertise in molecular toxicology and disease mechanisms.

CONTRIBUTIONS AND RESEARCH FOCUS ON INFECTIOUS DISEASES🧪

Dr. Shi’s research is focused on the metabolism and biological toxicity of metal ions such as iron, copper, and cadmium. His work is crucial in understanding how these metals impact biological systems, particularly in the context of heavy metal nephropathy. Additionally, his innovative work on the use of cell-free circulating cfDNA in blood as a biomarker for tissue cell damage has broad applications in medical diagnostics and environmental toxicology. His experimental models, which include yeast, silkworms, and mice, have helped to clarify the toxicological effects of metals at both molecular and systemic levels.

IMPACT AND INFLUENCE 🌍

Dr. Shi’s contributions to the scientific community are widely recognized. He has published over 70 research papers in prestigious international journals. One of his papers was recommended by Professor Alan Parrish from the University of Missouri-Columbia and listed by "Faculty Opinions" (formerly F1000Prime), a distinction reserved for papers with significant impact on their field. Another of his publications has been selected as an ESI Highly Cited Paper, placing him among the top 1% of researchers in his field.

ACADEMIC CITATIONS 📚

Dr. Shi’s work is highly cited, and his recognition as an ESI Highly Cited Researcher underscores his influence on the global scientific community. His papers continue to guide researchers in the fields of toxicology, nephropathy, and medical diagnostics.

LEGACY AND FUTURE CONTRIBUTIONS 🏅

Dr. Shi Haifeng’s legacy lies in his groundbreaking work on the biological effects of heavy metals and his innovative use of cfDNA in disease detection. As a leader in his field, his future contributions are expected to expand the frontiers of biochemistry and toxicology, with significant implications for both environmental health and clinical medicine. His continued dedication to both research and education ensures that he will remain an influential figure in his field for years to come.

NOTABLE PUBLICATIONS 📑

"Cadmium promoted LPS-induced inflammation through TLR4/IκBα/NFκ-B signaling by increasing ROS-mediated incomplete autophagy" 

  • Authors: Guo, C. , Ruan, J. , Li, Z. , Gu, J. , Shi, H.
  • Journal: Ecotoxicology and Environmental Safety
  • Year: 2024

"From ferroptosis to cuproptosis, and calcicoptosis, to find more novel metals-mediated distinct form of regulated cell death" 

  • Authors: Gu, J. , Guo, C. , Ruan, J. , Gong, X. , Shi, H.
  • Journal: Apoptosis
  • Year: 2024

"Stimuli-triggered multilayer films in response to temperature and ionic strength changes for controlled favipiravir drug release" 

  • Authors: Xu, L. , He, L. , Li, Y. , Shi, H. , Zhu, C.
  • Journal: Biomedical Materials (Bristol)
  • Year: 2024

"Energy storage enabled by cross-linked multilayer films using block copolymer-modified nanocapsules and chitosan biopolymers" 

  • Authors: Xu, L. , Li, Y. , Cai, T. , Chu, Z. , Shen, X
  • Journal: Macromolecular Research
  • Year: 2024

"Analysis of the primary factors influencing donor derived cell-free DNA testing in kidney transplantation" 

  • Authors: Cao, C. , Yuan, L. , Wang, Y. , Shi, H. , Jiang, T.
  • Journal: Frontiers in Immunology
  • Year: 2024

Youxin Wang | Epidemiology | Best Researcher Award 

Prof Youxin Wang | Epidemiology | Best Researcher Award 

North China University of Science and Technology | China

Author Profile

Scopus

Orcid ID

📚 YOUXIN WANG: A TRAILBLAZER IN PUBLIC HEALTH AND EPIDEMIOLOGY

EARLY ACADEMIC PURSUITS 🎓

Youxin Wang began her distinguished academic journey at the University of the Chinese Academy of Sciences, where she pursued a Ph.D. in Chemistry and Molecular Biology from 2005 to 2008. Her foundational training in this highly interdisciplinary field laid the groundwork for her future endeavors in public health, epidemiology, and health statistics. This early academic excellence positioned her as a versatile researcher capable of bridging molecular sciences with public health concerns.

PROFESSIONAL ENDEAVORS 👩‍🏫

Youxin Wang has held several prestigious positions, marking her steady ascent through academia:

  • Professor at the North China University of Science and Technology (2023 - Present): Currently, she holds the position of Professor at the School of Public Health, where she continues to expand her research and influence.
  • Professor at Capital Medical University (2019 - 2022): At the Department of Epidemiology and Health Statistics, she contributed to key public health initiatives and academic research.
  • Associate Professor at Capital Medical University (2014 - 2018): During this time, Wang honed her skills in teaching and mentoring the next generation of health professionals.
  • Lecturer at Capital Medical University (2008 - 2013): Her initial role at the same institution, where she laid the foundation of her teaching and research career.

CONTRIBUTIONS AND RESEARCH FOCUS ON EPIDEMIOLOGY🔬

Youxin Wang's research has focused on epidemiology, particularly in the fields of health statistics and the intersection of molecular biology and public health. She received funding from the National Natural Science Foundation of China for her groundbreaking project, Significance of Plasma N-glycome in Predicting Type 2 Diabetes and the Glycome-Genome Association Study (2014 - 2017). This research aimed to better understand the genomic predictors of diabetes, offering valuable insights for early diagnosis and treatment.

IMPACT AND INFLUENCE 🌍

Throughout her career, Youxin Wang has contributed to significant developments in public health, particularly in epidemiological methods and the study of chronic diseases like diabetes. Her role as an Adjunct Professor at Edith Cowan University (2020 - Present) reflects her international influence and collaborative efforts in advancing global health research. She has mentored students and professionals, shaping the future of public health research.

ACADEMIC CITES AND RECOGNITION 🏆

With a robust publication record and numerous citations, Youxin Wang’s work has been recognized both in China and internationally. Her innovative research on the plasma N-glycome and its role in diabetes prediction has garnered significant attention in epidemiological and biochemical research circles.

LEGACY AND FUTURE CONTRIBUTIONS 🌟

Youxin Wang's lasting legacy lies in her integrative approach to public health, combining molecular biology with epidemiology to address real-world health issues. As she continues her professorship at North China University of Science and Technology, she is poised to make further advancements in public health, with a focus on chronic disease prediction and prevention. Her ongoing research and mentorship will undoubtedly continue to influence both the scientific community and healthcare systems worldwide.

NOTABLE PUBLICATIONS 📑

"Associations of metabolic changes and polygenic risk scores with cardiovascular outcomes and all-cause mortality across BMI categories: a prospective cohort study" 

  • Authors: Li, C. , Meng, X. , Zhang, J. , Sun, S. , Wang, Y.
  • Journal: Cardiovascular Diabetology
  • Year: 2024

"Association between inflammatory bowel disease and cancer risk: evidence triangulation from genetic correlation, Mendelian randomization, and colocalization analyses across East Asian and European populations" 

  • Authors: Liu, D. , Cao, M. , Wang, H. , Li, Y. , Wang, Y.
  • Journal: BMC Medicine
  • Year: 2024

"Lifestyle intervention in children with obesity and nonalcoholic fatty liver disease (NAFLD): study protocol for a randomized controlled trial in Ningbo city (the SCIENT study)" 

  • Authors: Zhang, P.-P. , Wang, Y.-X. , Shen, F.-J. , Wang, H. , Li, L.
  • Journal: Trials
  • Year: 2024

"Potentially causal association between immunoglobulin G N-glycans and cardiometabolic diseases: Bidirectional two-sample Mendelian randomization study" 

  • Authors: Meng, X. , Liu, D. , Cao, M. , Wang, W. , Wang, Y.
  • Journal: International Journal of Biological Macromolecules
  • Year: 2024

"Establish a noninvasive model to screen metabolic dysfunction-associated steatotic liver disease in children aged 6–14 years in China and its applications in high-obesity-risk countries and regions" 

  • Authors: Liu, Y. , Wang, Y. , Xing, Y. , Wang, H. , Song, Y.
  • Journal: The Lancet Regional Health - Western Pacific
  • Year: 2024